SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission.
Hamblin, Peter S
SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission. [electronic resource] - The Journal of clinical endocrinology and metabolism 08 2019 - 3077-3087 p. digital
Publication Type: Journal Article; Multicenter Study
1945-7197
10.1210/jc.2019-00139 doi
Adult
Aged
Aged, 80 and over
Blood Glucose--analysis
Diabetes Mellitus, Type 2--blood
Diabetic Ketoacidosis--chemically induced
Female
Hospitalization
Humans
Male
Middle Aged
Retrospective Studies
Sodium-Glucose Transporter 2 Inhibitors--adverse effects
SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission. [electronic resource] - The Journal of clinical endocrinology and metabolism 08 2019 - 3077-3087 p. digital
Publication Type: Journal Article; Multicenter Study
1945-7197
10.1210/jc.2019-00139 doi
Adult
Aged
Aged, 80 and over
Blood Glucose--analysis
Diabetes Mellitus, Type 2--blood
Diabetic Ketoacidosis--chemically induced
Female
Hospitalization
Humans
Male
Middle Aged
Retrospective Studies
Sodium-Glucose Transporter 2 Inhibitors--adverse effects